A randomized controlled multicenter study comparing recombinant interleukin 2 (rIL-2) in conjunction with recombinant interferon alpha (IFN-alpha) versus no immunotherapy for patients with malignant lymphoma postautologous stem cell transplantation (Q40359531)
Jump to navigation
Jump to search
scientific article published on April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized controlled multicenter study comparing recombinant interleukin 2 (rIL-2) in conjunction with recombinant interferon alpha (IFN-alpha) versus no immunotherapy for patients with malignant lymphoma postautologous stem cell transplantation |
scientific article published on April 2010 |
Statements
1 reference
A randomized controlled multicenter study comparing recombinant interleukin 2 (rIL-2) in conjunction with recombinant interferon alpha (IFN-alpha) versus no immunotherapy for patients with malignant lymphoma postautologous stem cell transplantation (English)
1 reference
Avichai Shimoni
1 reference
Arnon Nagler
1 reference
Raanan Berger
1 reference
Aliza Ackerstein
1 reference
Jaroslaw A Czyz
1 reference
Jose Luis Diez-Martin
1 reference
Elizabeth Naparstek
1 reference
Reuven Or
1 reference
Shlomit Gan
1 reference
Shimon Slavin
1 reference
1 April 2010
1 reference
1 reference
Identifiers
1 reference